ClinicalTrials.Veeva

Menu

Toric Intraocular Lens Implantation in Pediatric Cataract (TILIPC)

K

Kazakh Eye Research Institute

Status

Active, not recruiting

Conditions

Cataract Congenital
Astigmatism
IOL

Treatments

Procedure: congenital/pediatric cataract surgery
Device: Toric IOLs
Device: Non-Toric IOLs

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT06294795
02-2024

Details and patient eligibility

About

To evaluate the visual and refractive outcomes after an intraocular lens (IOL) implantation in pediatric eyes with cataract and preexisting corneal astigmatism

Full description

This single-center, single-blinded, prospective, randomized controlled trial was performed at two sites of Kazakh Eye Research Institute.

Children with pediatric cataract and corneal astigmatism were included and randomized to two groups for pediatric cataract surgery with toric and non-toric intraocular lens (IOL) implantation. The uncorrected and corrected distance visual acuity, near visual acuity, keratometry data, and residual astigmatism were evaluated.

The purpose of this study is to evaluate the visual and refractive outcomes after a toric IOL implantation in pediatric eyes with cataract and preexisting corneal astigmatism.

Enrollment

40 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Visually significant cataract;
  2. Corneal astigmatism more than 1.25 diopters;
  3. Children aged ≥ 6 years and < 18 years.

Exclusion criteria

  1. Patients with a corneal diameter less than 9 mm;
  2. Presence of corneal scarring;
  3. Irregular astigmatism;
  4. Intraocular pressure more than 25 mm Hg;
  5. Active inflammatory process of the eyeball or signs of a previous episode of inflammation;
  6. Traumatic, subluxated, or complicated cataract;
  7. Persistent Fetal Vasculature;
  8. Diseases of the optic nerve or macula that may limit visual potential;
  9. History of previous intraocular surgeries;
  10. Performing posterior capsulorhexis intraoperatively.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Toric
Experimental group
Description:
A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx
Treatment:
Device: Toric IOLs
Procedure: congenital/pediatric cataract surgery
Non-toric
Active Comparator group
Description:
A folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF
Treatment:
Device: Non-Toric IOLs
Procedure: congenital/pediatric cataract surgery

Trial contacts and locations

2

Loading...

Central trial contact

Kairat Ruslanuly, MD; Lukpan Orazbekov, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems